Found 19 matching trials
Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN PHASE2 This study evaluate the regional (neck) nodal control of durvalumab in comb...
Show More Status
Active Not Recruiting
Location
Institut Sainte Catherine
Learn More & Join Trial
Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma PHASE2 Neoadjuvant chemo- and immunotherapy ameliorate the recurrence rate of chol...
Show More Location
Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale
Learn More & Join Trial
Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas. PHASE1 A phase Ib trial study of trabectedin when prescribed in combination with d...
Show More Location
Institut Bergonié
Learn More & Join Trial
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) PHASE3 This is a Phase III, randomized, open-label, 3-arm, multicenter, internatio...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer PHASE1 DESTINY-Breast 08 will investigate the safety, tolerability, PK and prelimi...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations PHASE3 This is a Phase III, randomized, open-label, multicenter, global study to c...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy PHASE2 This is an open-label, multi-centre, umbrella Phase II study in participant...
Show More Status
Active Not Recruiting
Learn More & Join Trial
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer PHASE2 The purpose of this study is to further advance the ability to practice per...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma PHASE1 The prognosis of patients with locally advanced SCCHN is poor. Results of r...
Show More Learn More & Join Trial
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment PHASE3 A global study to assess the efficacy and safety of durvalumab in combinati...
Show More Status
Active Not Recruiting
Learn More & Join Trial